Email updates

Keep up to date with the latest news and content from Diagnostic Pathology and BioMed Central.

Open Access Short report

The relative test performance characteristics of two commercial assays for the detection of Mycobacterium tuberculosis complex in paraffin-fixed human biopsy specimens

Steven J Drews124*, AliReza Eshaghi1, Daria Pyskir1, Pam Chedore1, Ernesto Lombos1, George Broukhanski1, Rachel Higgins1, David N Fisman13, Joanne Blair1 and Frances Jamieson14

Author Affiliations

1 Public Health Laboratories Branch, Ministry of Health and Long-Term Care, Toronto, Ontario, Canada

2 Department of Microbiology, Mount Sinai Hospital, Toronto, Ontario, Canada

3 Hospital for Sick Children, Toronto, Ontario, Canada

4 Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada

For all author emails, please log on.

Diagnostic Pathology 2008, 3:37  doi:10.1186/1746-1596-3-37

Published: 8 September 2008

Abstract

The Seeplex™ TB Detection-2 assay (Rockville, MD) is a nested endpoint PCR for the Mycobacterium tuberculosis complex (MTBC) targets IS6110 and MPB64 that utilizes dual priming oligonucleotide technology. When used to detect the presence of MTBC DNA in formalin-fixed paraffin-embedded tissue specimens, the sensitivity and specificity of this assay is equivalent to a labor-intensive traditional endpoint PCR assay and is more sensitive than a commercial real-time PCR assay.